Despite randomized clinical trials and adverse reaction reporting schemes, the cost caused by adverse drug reactions is estimated to exceed 5 billion dollars in the Netherlands annually. Some examples illustrate why we fail to predict drug-induced morbidity both quantitatively and qualitatively.
|Translated title of the contribution||Practice shows what can go wrong. Pharmacoepidemiology as an instrument for assessing drugs|
|Number of pages||4|
|Publication status||Published - 4 Dec 1998|
- Adverse drug reaction reporting systems
- Adverse effects
- Clinical trials
- Economies, pharmaceutical